These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35152870)

  • 61. ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling.
    Pan S; Liang S; Wang X
    Life Sci; 2021 Aug; 278():119581. PubMed ID: 33961854
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Andrographolide inhibits the growth of human osteosarcoma cells by suppressing Wnt/β-catenin, PI3K/AKT and NF-κB signaling pathways.
    Huang H; Lu Q; Yuan X; Zhang P; Ye C; Wei M; Yang C; Zhang L; Huang Y; Luo X; Luo J
    Chem Biol Interact; 2022 Sep; 365():110068. PubMed ID: 35917943
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antitumor effects of flavokawain-B flavonoid in gemcitabine-resistant lung cancer cells are mediated via mitochondrial-mediated apoptosis, ROS production, cell migration and cell invasion inhibition and blocking of PI3K/AKT Signaling pathway.
    Hua R; Pei Y; Gu H; Sun Y; He Y
    J BUON; 2020; 25(1):262-267. PubMed ID: 32277640
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway.
    Chen R; Fang T; Liu N; Shi X; Wang J; Yu H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2269-2280. PubMed ID: 37812238
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Propofol Improves Sensitivity of Lung Cancer Cells to Cisplatin and Its Mechanism.
    Huang Y; Lei L; Liu Y
    Med Sci Monit; 2020 Mar; 26():e919786. PubMed ID: 32225124
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Propofol inhibits colon cancer cell stemness and epithelial-mesenchymal transition by regulating SIRT1, Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways.
    Wang R; Li S; Hou Q; Zhang B; Chu H; Hou Y; Ni C; Sun L; Ran Y; Zheng H
    Discov Oncol; 2023 Jul; 14(1):137. PubMed ID: 37490168
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Decreasing of serine/threonine kinase 39 has tumour inhibiting effects on acute myeloid leukaemia by impacting the PI3K/AKT and Wnt/β-catenin signalling cascades.
    Li C; Xin H; Hao J; Miao Y
    Toxicol Appl Pharmacol; 2024 Aug; 489():116982. PubMed ID: 38821216
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Wnt/β-catenin signaling pathway in lung cancer stem cells is a potential target for the development of novel anticancer drugs.
    Jiang HL; Jiang LM; Han WD
    J BUON; 2015; 20(4):1094-100. PubMed ID: 26416062
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells.
    He J; Shi J; Zhang K; Xue J; Li J; Yang J; Chen J; Wei J; Ren H; Liu X
    Mol Med Rep; 2017 Apr; 15(4):1693-1701. PubMed ID: 28259951
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MiR-208a participates with sevoflurane post-conditioning in protecting neonatal rat cardiomyocytes with simulated ischemia-reperfusion injury via PI3K/AKT signaling pathway.
    Shi HH; Wang ZQ; Zhang S
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):943-955. PubMed ID: 32017002
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
    Duan W; Liu X
    Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CircLMTK2 acts as a tumor suppressor in prostate cancer via regulating the expression of microRNA-183.
    Jin C; Zhao W; Zhang Z; Liu W
    Life Sci; 2020 Jan; 241():117097. PubMed ID: 31760099
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Study of the mechanism by which Xiaoyan decoction combined with E7449 regulates tumorigenesis in lung adenocarcinoma.
    Zheng X; Han Y; Gu L; Gao S; Lv Y; Li C
    J Cell Mol Med; 2024 Jun; 28(12):e18467. PubMed ID: 38898581
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers.
    Reddy D; Kumavath R; Tan TZ; Ampasala DR; Kumar AP
    Life Sci; 2020 Jan; 241():117147. PubMed ID: 31830480
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer.
    Yu W; Hua Y; Qiu H; Hao J; Zou K; Li Z; Hu S; Guo P; Chen M; Sui S; Xiong Y; Li F; Lu J; Guo W; Luo G; Deng W
    Cell Death Dis; 2020 Jul; 11(7):506. PubMed ID: 32632098
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
    Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
    Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Crosstalk between PI3K/Akt and Wnt/β-catenin pathways promote colorectal cancer progression regardless of mutational status.
    Fleming-de-Moraes CD; Rocha MR; Tessmann JW; de Araujo WM; Morgado-Diaz JA
    Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 35944058
    [TBL] [Abstract][Full Text] [Related]  

  • 78. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
    Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
    Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM; Bai JY; Yang KX
    IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5.
    Ren F; Su H; Jiang H; Chen Y
    J Cell Biochem; 2020 Jan; 121(1):213-223. PubMed ID: 31190447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.